Cargando…

Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes

ABSTRACT: The SGLT2 inhibitor empagliflozin improved cardiovascular outcomes in patients with diabetes. As the cardiac mechanisms remain elusive, we investigated the long-term effects (up to 2 months) of empagliflozin on excitation-contraction (EC)-coupling in human cardiomyocytes derived from induc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pabel, Steffen, Reetz, Florian, Dybkova, Nataliya, Shomroni, Orr, Salinas, Gabriela, Mustroph, Julian, Hammer, Karin P., Hasenfuss, Gerd, Hamdani, Nazha, Maier, Lars S., Streckfuss-Bömeke, Katrin, Sossalla, Samuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679329/ https://www.ncbi.nlm.nih.gov/pubmed/33034709 http://dx.doi.org/10.1007/s00109-020-01989-6

Ejemplares similares

Inhibition of Na(V)1.8 prevents atrial arrhythmogenesis in human and mice
por: Pabel, Steffen, et al.
Publicado: (2020)

Molecular and Functional Relevance of Na(V)1.8-Induced Atrial Arrhythmogenic Triggers in a Human SCN10A Knock-Out Stem Cell Model
por: Hartmann, Nico, et al.
Publicado: (2023)

The functional consequences of sodium channel Na(V)1.8 in human left ventricular hypertrophy
por: Ahmad, Shakil, et al.
Publicado: (2018)

Detrimental proarrhythmogenic interaction of Ca(2+)/calmodulin-dependent protein kinase II and Na(V)1.8 in heart failure
por: Bengel, Philipp, et al.
Publicado: (2021)

Empagliflozin inhibits Na(+)/H(+) exchanger activity in human atrial cardiomyocytes
por: Trum, Maximilian, et al.
Publicado: (2020)

Empagliflozin reduces Ca/calmodulin‐dependent kinase II activity in isolated ventricular cardiomyocytes
por: Mustroph, Julian, et al.
Publicado: (2018)

Effects of Atrial Fibrillation on the Human Ventricle
por: Pabel, Steffen, et al.
Publicado: (2022)

SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?
por: Pabel, Steffen, et al.
Publicado: (2021)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Peroxisomes contribute to intracellular calcium dynamics in cardiomyocytes and non-excitable cells
por: Sargsyan, Yelena, et al.
Publicado: (2021)

The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases
por: Zhazykbayeva, Saltanat, et al.
Publicado: (2020)

Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II
por: Mustroph, Julian, et al.
Publicado: (2022)

Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes
por: Seibertz, Fitzwilliam, et al.
Publicado: (2023)

A High-Throughput Method as a Diagnostic Tool for HIV Detection in Patient-Specific Induced Pluripotent Stem Cells Generated by Different Reprogramming Methods
por: Hübscher, Daniela, et al.
Publicado: (2019)

Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients
por: Haupt, Luis Peter, et al.
Publicado: (2022)

A novel single-cell RNA-sequencing approach and its applicability connecting genotype to phenotype in ageing disease
por: Shomroni, Orr, et al.
Publicado: (2022)

Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
por: Hassoun, Roua, et al.
Publicado: (2021)

Tampering with springs: phosphorylation of titin affecting the mechanical function of cardiomyocytes
por: Hamdani, Nazha, et al.
Publicado: (2017)

Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2
por: A Nabeebaccus, Adam, et al.
Publicado: (2021)

Enhanced cardiac TBC1D10C expression lowers heart rate and enhances exercise capacity and survival
por: Volland, Cornelia, et al.
Publicado: (2016)

Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin
por: Jakob, Mark, et al.
Publicado: (2020)

SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress
por: Tangos, Melina, et al.
Publicado: (2022)

Excitation–contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes
por: Kane, Christopher, et al.
Publicado: (2015)

Sacubitrilat reduces pro‐arrhythmogenic sarcoplasmic reticulum Ca(2+) leak in human ventricular cardiomyocytes of patients with end‐stage heart failure
por: Eiringhaus, Jörg, et al.
Publicado: (2020)

A quantitative RT-PCR protocol to adapt and quantify RBM20-dependent exon splicing of targets at the human locus
por: Rebs, Sabine, et al.
Publicado: (2022)

Tachycardiomyopathy entails a dysfunctional pattern of interrelated mitochondrial functions
por: Paulus, Michael G., et al.
Publicado: (2022)

Optical modulation of excitation-contraction coupling in human-induced pluripotent stem cell-derived cardiomyocytes
por: Vurro, Vito, et al.
Publicado: (2023)

CRISPLD1: a novel conserved target in the transition to human heart failure
por: Khadjeh, Sara, et al.
Publicado: (2020)

Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
por: Kruse, Vanessa, et al.
Publicado: (2015)

Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
por: Juni, Rio P., et al.
Publicado: (2019)

Intracoronary pyruvate in cardiogenic shock as an adjunctive therapy to catecholamines and intra-aortic balloon pump shows beneficial effects on hemodynamics
por: Schillinger, Wolfgang, et al.
Publicado: (2010)

Empagliflozin and Dapagliflozin Increase Na(+) and Inward Rectifier K(+) Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells (hiPSC-CMs)
por: Dago, María, et al.
Publicado: (2022)

Cell-Target-Specific Anti-Inflammatory Effect of Empagliflozin: In Vitro Evidence in Human Cardiomyocytes
por: Giannattasio, Silvia, et al.
Publicado: (2022)

Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
por: Ng, Kwong-Man, et al.
Publicado: (2018)

C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
por: Michel, Konstanze, et al.
Publicado: (2020)

Structural Analysis of Mitochondrial Dynamics—From Cardiomyocytes to Osteoblasts: A Critical Review
por: Mendelsohn, Daniel H., et al.
Publicado: (2022)

Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes
por: Scisciola, Lucia, et al.
Publicado: (2023)

Fine Structure in Electronic Spectra of Cyanine Dyes: Are Sub‐Bands Largely Determined by a Dominant Vibration or a Collection of Singly Excited Vibrations?
por: Mustroph, Heinz, et al.
Publicado: (2018)

Excitation–Contraction Coupling of the Mouse Embryonic Cardiomyocyte
por: Rapila, Risto, et al.
Publicado: (2008)

Enhanced Heart Failure in Redox‐Dead Cys17Ser PKARIα Knock‐In Mice
por: Islam, M. M. Towhidul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u83j56c0ssvlgdlpra855g6qml